Latest News

CE Mark for Endoform® Dermal Template11 Apr 2017

Aroa Biosurgery has received CE mark for its Endoform® Dermal Template (“EDT”), which allows the company to market and sell this device in the European markets.

Continue Reading

510(k) Clearance Received for Endoform® Plastics and Reconstructive Matrix20 Dec 2016

Aroa Biosurgery has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for the company’s Endoform® Plastics and Reconstructive Matrix, which allows the company to market and sell this device in the USA.

Continue Reading

Aroa Biosurgery successfully raises additional capital to fund growth14 Oct 2016

Aroa Biosurgery has successfully raised additional capital from new and existing investors from the USA, Australia and New Zealand.

Continue Reading
123Next ›